Virtual Oncology Market is expected to grow at a CAGR of 18.1% during the forecasted period | Evolve Business Intelligence

Key Highlights:
• The global Virtual Oncology Market size was valued at USD 4.1 billion in 2023 growing at a CAGR of 18.1% from 2023 to 2033.
• North America dominated the market in 2023
• Asia Pacific is expected to grow at the highest CAGR from 2023 to 2033

As per the study initiated by Evolve Business Intelligence, the global Virtual Oncology Market size accounted for USD 4.1 Billion in 2023, growing at a CAGR of 18.1% from 2023 to 2033. Virtual oncology primarily refers to the integration of virtual technologies and telemedicine in the field of oncology (cancer care). These technologies aim to enhance patient care, improve access to oncology services, and streamline communication among healthcare professionals.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021489

Virtual oncology allows for the remote monitoring of cancer patients, enabling healthcare providers to track symptoms, side effects of treatments, and overall health. This can improve patient outcomes and reduce the need for frequent hospital visits. Virtual consultations and telemedicine platforms enable oncologists to connect with patients without the need for in-person visits. This is particularly beneficial for patients who may live in remote areas or have difficulty traveling to healthcare facilities. Virtual oncology facilitates the sharing of medical records, test results, and treatment plans among healthcare professionals. This collaborative approach can lead to more informed decision-making and personalized treatment strategies.

Key Players
Some of the major Virtual Oncology Market players holding high market shares include Flatiron Health, McKesson Corporation, Cerner Corporation, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Crisp, Varian Medical Systems, Inc. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Elekta AB, Accuray Incorporated, C-TAC Health, Oscar Health, NXGN Management, LLC, Epic Systems Corporation, Optum, Inc, Orchestrate.AI, CureMatch, Inc., Oncora Medical, Massive Bio, Inc., Dell Technologies

For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021489

Segmental Analysis
Based on components, the Virtual Oncology market is segmented into Software, Service, and Hardware. The largest segment of the Virtual Oncology market by component is software. This is due to the increasing adoption of virtual oncology software solutions by hospitals, academic institutions, and pharmaceutical companies. Virtual oncology software solutions are used for a variety of purposes, including precision medicine, patient care management, research and development, and clinical trials.
Based on Cancer Type, the Virtual Oncology market is Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, and Others (Pancreatic, Ovarian, etc.). The largest segment of the Virtual Oncology market by cancer type is lung cancer. This is due to the high prevalence of lung cancer and the increasing demand for effective treatment options. Virtual oncology solutions are being used to develop new lung cancer treatments, improve patient care, and conduct clinical trials.
Based on Application, the Virtual Oncology market is a Precision Medicine, Patient Care Management, Research and development, Clinical Trials, Diagnosis and Treatment Decision Making, Data Management, and Others (Billing Management, Regulatory Compliance, etc.). The largest segment of the Virtual Oncology market by application is precision medicine. Precision medicine is a personalized approach to cancer treatment that takes into account the individual patient's genetic makeup, tumor characteristics, and other factors. Virtual oncology solutions are being used to develop precision medicine treatment plans, monitor patient response to treatment, and identify new targets for therapy.
Based on End Use, the Virtual Oncology market is Hospitals and Diagnostic Imaging Centers, Academic Institutions and Research Centers, Pharma and biotech Companies, Contract Research Organizations (CROs), and Others (Reference Laboratories, Pharmacies, etc.). The largest segment of the Virtual Oncology market by end-use is hospitals and diagnostic imaging centers. Hospitals and diagnostic imaging centers are the primary users of virtual oncology solutions due to their need for accurate diagnosis, effective treatment, and efficient patient care management. Virtual oncology solutions are being used to improve patient outcomes, reduce costs, and enhance the overall quality of care.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.